FIRM ANALYSIS CANADA
Firm Briefings
ment. Armitage has also negotiated a large number of contract research services agreements with companies like KBI Biopharma and Charles River Laboratories. His colleague, Vanessa Grant, is regarded by a peer as “an expert in life sciences transactions and a pleasure to work with for a client.” Grant advised YM BioSciences on its sale to Gilead Sciences for approximately $510 million. Product Liability: Rounding out Gowlings’s all-around practice is their exceptional product liability group. “The team is one of the best products groups in any industry in the country,” believes one practitioner. “Their litigation experience in other industries allowed them to take advantage of their skills and resources to become a leader in life sciences.” Partner Mary Thomson is the firm’s national leader of the product liability practice group and has a vast amount of first-chair trial experience all over the country. A rival attorney refers to her as, “everything you want in a product liability attorney because no one is a better courtroom strategist.” Thompson has been lead counsel for both GlaxoSmithKline and Hoffman-La Roche in separate product liability proceedings. Much like the other practice areas at the firm, clients rave about thei "W?W&?V?6Rv?&???rv?F?F?R&?GV7B?&??G?GF?&?W?2???R6?V?BFW67&?&W2F?V?"v?&?v?F?F?Rw&?W2( ?F?RV6?W7B?B??7B&V77W&??r?Vv??67W'&V?6R??fRWfW"FV?Bv?F???????GW7G'??( ?FF??rF?B( ?F?W?&V??WBF?V?"6?V?BBV6R?BF?V?&R&?RF?f????rF?&?Vv???F?V?"&??6W2?( ??VV??&????R??FV??V7GV?&?W'G???VV??&????R?2??R?b6?F ( ?2( ???7B66???6?VB?&7F?6W>( ?66?&F??rF?VW'2?v???R??F?W"GF?&?W?6???V?G2F?Rf?&?( ?2( ?GFV?F???F?FWF????FV??rv?F???6?F???2FV?B?'Ff???2&?F?f?"f???w2?B??6?F???2?( ?&?F?F?R6??FV?F??W2?B????6??FV?F???2?FV?2v?&???6??6W'BGW&??r??g&??vV?V?B66W2???R??7F?6R?bF?Rw&?W( ?2FV?v?&?v2???G2&W&W6V?FF????b??f??&???FVB?BFWf?&?6WWF?6???GW7G&?W2???V?F??RFV?B??g&??vV?V?B7G2?'F?W"?W6?W?67vV??v?&?VB??F?R?GFW'2?B?2&Vv&FVB'?6???VwVW2f?"?W"( ?FV?B?'Ff?????vV?V?B6????2?B?WG7F?F??r&??G?F?f?7FW"&V?F???6??2v?F?6?V?G2?( ?67vV???2&V6??R??R?bF?R6?V?G'?( ?2?VF??rFV?BGF?&?W?2?B?27W?'FVBF?R??F?vF???FV????V?W&?W2?GFW'2???6?VF??r???V6??V?B7F????B???2?6F?????f??f??r6?V?BFWf???v??6?F?W?'&?vVBvV?W&?2??Vf7GW&W'2??????B??f?F?G?6???v??7B'&?FVB??Vf7GW&W"?'F?W"???F??7F??6'??VG2?VV??&????^( ?2??F?vF???w&?W?B?2&?r&V6??v??F?Rf?&??2?B7V66W72??F?R?fR66?V?6W2??GW7G'??( ?R?2?VF??rFV?F?B?266???6?VB??B?b?6?F?fRF???w2f?"F?V?"6?V?G2?BF?W?6??F??VRF?&Rf?&6R?( ?7FFW2??R&7F?F???W"?F?Rf?&?&W&W6V?G2FWf?&?6WWF?6?( ?26?F??&???v?FRf&?WG??b?GFW'2??6?VF??r?&?6WWF?6?FV?B??g&??vV?V?B7F???2?B???V?7F????2vV??2???2?F?vF????7F??6'??2( ??6?72?b??2?v?v?V??B6??W2F???F?vF???( ?66?&F??rF???R6??WF?F?"????rv?F?'F?W"&???????v????R6???VwVR&V?WfW2?2( ???R?bF?R??&RfW'6F??R&7F?6W2??F?R??GW7G'??( ?7F??6'??27V66W76gV??&W&W6V?FVB6??R?b&?vvW7B?fR66?V?6W26????W2??6?F??R6??F??VW2F?&W&W6V?BFWf??FV?B7V?Bv??7BVƒ????v?W&RgFW"???R?V'2?b?F?vF????F?R6?W'Bf?V?BF?BVƒ???( ?2FV?Bf?"?F?7?6??F?2G'Vr??????Rv2??f?B?B?Bv27W7F??VBv?V?F?R7W&V?R6?W'BF?6?76VB???( ?2?6F???f?"?VfRF?V??&?GV7B?&??G??( ?v?V???R?fRFV?F?B?W7B???w2??rF??F?vFR??6?W'G&????F?W?&Rv???rF?vWB6?V?G2F?B?VVBW?6WF????&W&W6V?FF???F???R7W&R?????2&V?( ?B??7B?( ?W????2??R&7F?F???W"&?WBF?R?F?vF???w&?WB?VV??&????R?f?&?&W6V?B??6??R?bF?R?&vW7B6?727F???7V?G2??6?F????7F?'???VV??&????R&W&W6V?FVB?&?6WWF?6?6????W2???6?F?b?&?6???6?727F???66R?fW"F?RW6R?bF?RvV?B?&?vR??F'??W&&?6?FW2W6VB??F?R?c( ?2???FF?F????F?W?&R&W&W6V?F??r6?V?BFWf?&?6WWF?6?2v??7BVƒ?????6?727F???&?6VVF??w2&6VB??VV&V2???F&????B'&?F?6?6??V?&??F?W6RG&??2&R&Vv&F??r&?GV7B?&??G???VvF???2&Vv&F??rF?RW6R?b??F??FW&W76?B?VF?6F???F?BVƒ???v2&VgW6VBF?R&??G?F?V?'?&?f??6??6?W'G2??V?7??W"6?v?B&?GV7B?&??G??VW'2?'fV?B?V?7??W"6?v?N( ?2?F?vF?'2??&?GV7B?&??G??B6?727F????GFW'2v?F????fR66?V?6W2?( ?F?W??fR??FgV??b?VB6?V?6V??w?W'2v??&RfW'?F?V?FVB??F?R6?W'G&????( ?6?2??R???F?W"&?f?GF?&?W?FW67&?&W2F?Rf?&?( ?26&??F?W22( ?V??VR&V6W6RF??2?2v?BF?W?f?7W2?????fR66?V?6W2??BF?W?F??( ?BFWf?FR?V6?F??F?W"&V2?bF?R??GW7G'??B?Bv?fW2F?V??Gf?FvR??6??Rv?2?( ??VF??rWF?R&?fW76?????&??G?w&?WBF?Rf?&?&R'F?W"F??7W''??Bf?V?F??r'F?W"?6?V?&??6R?&??6R?2??R?bF?Rf?&?( ?2f?fRf?V?F??r'F?W'2?B?2f?WvVB'?6???VwVW22( ?????'F?B??f?VV?6R??&?fW76?????&??G?&?6VVF??w2??6?F?( ?v???R&??6R?2fW'?vV?????v???F?R??GW7G'??7W''??2&VV?fW'?7F?fR2?b?FR??Rv26?V?6V?F?&??&??6?F?VV&V2&6VB6???????6?727F?????Vv??r?7&W&W6V?FF???2??F?R?&?WF??r?b???V?F??2?VF?6??R&?GV7G2?( ?F???2????r??F??2&V?BFW6W'fW2F?&R&V6?v?VBf?"??2v?&??( ?&wVW2??R&?f???46'F??L:?G&V?B??FV??V7GV?&?W'G??F?R??F?vF???&7F?6RB?46'F??L:?G&V?B&W&W6V?G26??R?bF?R??GW7G'?( ?2&?vvW7B??W'2???RVW"?'fV?2BF?Rf?&?( ?2W?W&?V?6Rv?&???rv?F?7V6??fR66?V?6RF?F?2?( ?F?W?&R&?RF?GG&7B6????W2&V6W6RF?W?6??&??RF?V?"??B6?'?&FR6????2F??V?F?V?"6?V?G2F?F?R??7B???'F?BF???r??F?R??GW7G'??v??6??2??R???W??( ??W&6??B&&?GB?&?&F?&?W2&R?W7BGv??b?46'F??( ?2?FW7B6?V?G2?( ???R?bF?RF?wW?2??6?W'G&????B?2??Bg&?BF?F?R??66R?( ??2??r??RGF?&?W?FW67&?&W2'F?W"?G&Wr&VFF???&VFF???26??"?bF?Rf?&?( ?2?F??????FV??V7GV?&?W'G??F?vF???w&?W?B( ?2?F?vFVB?fW"??&R???W?F??6??R6????W2&RWfW"v?'F?( ?66?&F??rF?VW"???&V6V?B66Rf?"?W&6??&VFF??v2?VB6?V?6V??Bv?????"FV?BG&???fW"vV?v?B???72G'Vr??f7FF???6????r?fW"C#???????F?vW2?( ?vR??WrvRvW&R????rF?R&?v?BFV6?6???v?V?vR?6?V@????r?dR44?T?4U2#0??c??